NTBC as palliative treatment in chronic tyrosinaemia type I.
Ros
J
J
Unitat Integrada, Hospital Sant Joan de Déu/Hospital Clínic, Universitat de Barcelona, Spain.
Vilaseca
M A
MA
Lambruschini
N
N
Mas
A
A
Lindstedt
S
S
Holme
E
E
D015111:4-Hydroxyphenylpyruvate Dioxygenase / Q000037:antagonists & inhibitors*; D000293:Adolescent; D000592:Amino Acid Metabolism, Inborn Errors / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D003512:Cyclohexanones / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009579:Nitrobenzoates / Q000627:therapeutic use*; D014443:Tyrosine / Q000097:blood*
D003512:Cyclohexanones; D009579:Nitrobenzoates; D014443:Tyrosine; D015111:4-Hydroxyphenylpyruvate Dioxygenase; C077073:nitisinone